Altered Motivation and Learning Following Opiate Withdrawal: Evidence for Prolonged Dysregulation of Reward Processing (original) (raw)
Barr AM, Fiorino DF, Phillips AG (1999). Effects of withdrawal from an escalating dose schedule of D-amphetamine on sexual behavior in the male rat. Pharmacol Biochem Behav64: 597–604. ArticleCAS Google Scholar
Barr AM, Phillips AG (1999). Withdrawal following repeated exposure to D-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology141: 99–106. ArticleCAS Google Scholar
Cecchi M, Khoshbouei H, Javors M, Morilak DA (2002). Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience112: 13–21. ArticleCAS Google Scholar
Childress AR, McLellan AT, Natale M, O'Brien CP (1987). Mood states can elicit conditioned withdrawal and craving in opiate abuse patients. NIDA Res Monogr76: 137–144. CASPubMed Google Scholar
Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature403: 430–434. ArticleCAS Google Scholar
Di Chiara G (1998). A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol12: 54–67. ArticleCAS Google Scholar
Di Chiara G (1999). Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol375: 13–30. ArticleCAS Google Scholar
Gerra G, Calbiani B, Zaimovic A, Sartori R, Ugolotti G, Ippolito L et al (1998). Regional cerebral blood flow and comorbid diagnosis in abstinent opioid addicts. Psychiatry Res83: 117–126. ArticleCAS Google Scholar
Gold LH, Stinus L, Inturrisi CE, Koob GF (1994). Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol253: 45–51. ArticleCAS Google Scholar
Harris GC, Aston-Jones G (1993). _β_-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology113: 131–136. ArticleCAS Google Scholar
Harris GC, Aston-Jones G (2001). Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal. Neuropsychopharmacology24: 75–85. ArticleCAS Google Scholar
Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L (1995). Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol6: 74–80. ArticleCAS Google Scholar
Jaffe JH (1990). Drug addiction and abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. Pergamon: New York. pp 522–573. Google Scholar
Koob GF, Le Moal M (1997). Drug abuse: Hedonic homeostatic dysregulation. Science278: 52–58. ArticleCAS Google Scholar
Koob GF, Le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology24: 97–129. ArticleCAS Google Scholar
Kreek MJ (1973). Medical safety and side effects of methadone in tolerant individuals. J Am Med Assoc223: 665–668. ArticleCAS Google Scholar
Kreek MJ (1987). Multiple drug abuse patterns and medical consequences. In: Meltzer HY (ed). Psychopharmacolgy: The Third Generation of Progress. Raven Press: New York. pp 1597–1604. Google Scholar
Kreek MJ, Koob GF (1998). Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend51: 23–47. ArticleCAS Google Scholar
Krystal JH, Woods SW, Kosten TR, Rosen MI, Seibyl JP, van Dyck CC et al (1995). Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). Am J Drug Alcohol Abuse21: 47–63. ArticleCAS Google Scholar
Lee Y, Davis M (1997). Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci17: 6433–6446. Google Scholar
Martin WR, Jasinski DR (1969). Physiological parameters of morphine dependence in man—tolerance, early abstinence, protracted abstinence. J Psychiatry Res7: 9–17. ArticleCAS Google Scholar
Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ et al (2000). Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology23: 113–126. ArticleCAS Google Scholar
Sarnyai Z, Shaham Y, Heinrichs SC (2001). The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev53: 209–243. CASPubMed Google Scholar
Shaham Y, Erb S, Stewart J (2000). Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev33: 13–33. ArticleCAS Google Scholar
Shalev U, Grimm JW, Shaham Y (2002). Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev54: 1–42. ArticleCAS Google Scholar
Shippenberg TS, Elmer GI (1998). The neurobiology of opiate reinforcement. Crit Rev Neurobiol12: 267–303. ArticleCAS Google Scholar
Shippenberg TS, Heidbreder C, LeFevour A (1996). Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol. 299: 33–39. ArticleCAS Google Scholar
Solomon RL (1977). The opponent-process theory of acquired motivation: the affective dynamics of addiction. In: Maser JD, Seligman MEP (eds). Psychopathology: Experimental Models. WH Freeman and Co.: San Francisco. pp 124–145. Google Scholar
Solomon RL, Corbit JD (1974). An opponent-process theory of motivation: I. Temporal dynamics of affect. Psychol Rev81: 119–145. ArticleCAS Google Scholar
Yoburn BC, Chen J, Huang T, Inturrisi CE (1985). Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. J Pharmacol Exp Ther235: 282–286. CASPubMed Google Scholar